Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus

Abstract Regulation of blood glucose requires precise coordination between different endocrine systems and multiple organs. Type 2 diabetes mellitus (T2D) arises from a dysregulated response to elevated glucose levels in the circulation. Globally, the prevalence of T2D has increased dramatically in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhi Yang Tam, Sean Pin Ng, Ling Qiao Tan, Chih-Hsien Lin, Dietrich Rothenbacher, Jochen Klenk, Bernhard Otto Boehm, SPC Team, ActiFE Study Group
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/69343e65f84a4c9a91fbf0951728d1b4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:69343e65f84a4c9a91fbf0951728d1b4
record_format dspace
spelling oai:doaj.org-article:69343e65f84a4c9a91fbf0951728d1b42021-12-02T16:06:05ZMetabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus10.1038/s41598-017-01735-y2045-2322https://doaj.org/article/69343e65f84a4c9a91fbf0951728d1b42017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01735-yhttps://doaj.org/toc/2045-2322Abstract Regulation of blood glucose requires precise coordination between different endocrine systems and multiple organs. Type 2 diabetes mellitus (T2D) arises from a dysregulated response to elevated glucose levels in the circulation. Globally, the prevalence of T2D has increased dramatically in all age groups. T2D in older adults is associated with higher mortality and reduced functional status, leading to higher rate of institutionalization. Despite the potential healthcare challenges associated with the presence of T2D in the elderly, the pathogenesis and phenotype of late-onset T2D is not well studied. Here we applied untargeted metabolite profiling of urine samples from people with and without late-onset T2D using ultra-performance liquid-chromatography mass-spectrometry (UPLC-MS) to identify urinary biomarkers for late-onset T2D in the elderly. Statistical modeling of measurements and thorough validation of structural assignment using liquid chromatography tandem mass-spectrometry (LC-MS/MS) have led to the identification of metabolite biomarkers associated with late-onset T2D. Lower levels of phenylalanine, acetylhistidine, and cyclic adenosine monophosphate (cAMP) were found in urine samples of T2D subjects validated with commercial standards. Elevated levels of 5′-methylthioadenosine (MTA), which previously has only been implicated in animal model of diabetes, was found in urine of older people with T2D.Zhi Yang TamSean Pin NgLing Qiao TanChih-Hsien LinDietrich RothenbacherJochen KlenkBernhard Otto BoehmSPC TeamActiFE Study GroupNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Zhi Yang Tam
Sean Pin Ng
Ling Qiao Tan
Chih-Hsien Lin
Dietrich Rothenbacher
Jochen Klenk
Bernhard Otto Boehm
SPC Team
ActiFE Study Group
Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
description Abstract Regulation of blood glucose requires precise coordination between different endocrine systems and multiple organs. Type 2 diabetes mellitus (T2D) arises from a dysregulated response to elevated glucose levels in the circulation. Globally, the prevalence of T2D has increased dramatically in all age groups. T2D in older adults is associated with higher mortality and reduced functional status, leading to higher rate of institutionalization. Despite the potential healthcare challenges associated with the presence of T2D in the elderly, the pathogenesis and phenotype of late-onset T2D is not well studied. Here we applied untargeted metabolite profiling of urine samples from people with and without late-onset T2D using ultra-performance liquid-chromatography mass-spectrometry (UPLC-MS) to identify urinary biomarkers for late-onset T2D in the elderly. Statistical modeling of measurements and thorough validation of structural assignment using liquid chromatography tandem mass-spectrometry (LC-MS/MS) have led to the identification of metabolite biomarkers associated with late-onset T2D. Lower levels of phenylalanine, acetylhistidine, and cyclic adenosine monophosphate (cAMP) were found in urine samples of T2D subjects validated with commercial standards. Elevated levels of 5′-methylthioadenosine (MTA), which previously has only been implicated in animal model of diabetes, was found in urine of older people with T2D.
format article
author Zhi Yang Tam
Sean Pin Ng
Ling Qiao Tan
Chih-Hsien Lin
Dietrich Rothenbacher
Jochen Klenk
Bernhard Otto Boehm
SPC Team
ActiFE Study Group
author_facet Zhi Yang Tam
Sean Pin Ng
Ling Qiao Tan
Chih-Hsien Lin
Dietrich Rothenbacher
Jochen Klenk
Bernhard Otto Boehm
SPC Team
ActiFE Study Group
author_sort Zhi Yang Tam
title Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
title_short Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
title_full Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
title_fullStr Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
title_full_unstemmed Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
title_sort metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/69343e65f84a4c9a91fbf0951728d1b4
work_keys_str_mv AT zhiyangtam metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT seanpinng metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT lingqiaotan metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT chihhsienlin metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT dietrichrothenbacher metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT jochenklenk metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT bernhardottoboehm metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT spcteam metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
AT actifestudygroup metaboliteprofilinginidentifyingmetabolicbiomarkersinolderpeoplewithlateonsettype2diabetesmellitus
_version_ 1718385093826838528